A detailed history of Schonfeld Strategic Advisors LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 14,360 shares of PSNL stock, worth $59,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,360
Holding current value
$59,450
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.38 - $6.26 $48,536 - $89,893
14,360 New
14,360 $83,000
Q2 2022

Aug 15, 2022

BUY
$3.27 - $8.76 $279,912 - $749,856
85,600 New
85,600 $295,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $190M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.